National Bank Financial lowered shares of SNC-Lavalin Group (TSE:ATR – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Wednesday,Zacks.com reports. National Bank Financial also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.85 EPS, Q4 2025 earnings at $0.82 EPS, FY2025 earnings at $3.01 EPS and FY2026 earnings at $3.83 EPS.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Articles
- Five stocks we like better than SNC-Lavalin Group
- What is Short Interest? How to Use It
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Business Services Stocks Investing
- 3 Stocks Set to Double—And There’s Still Time to Buy
- What Are Growth Stocks and Investing in Them
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
-sa-logo-1200x675.png?v=20240109092235&h=45&w=95&zc=2){kind=logo}
